Key takeaways: The FDA has approved the world’s first vaccine for Respiratory Syncytial Virus (RSV) for adults aged 60 and up, made by GSK. The…
Key takeaways: The FDA has approved the world’s first vaccine for Respiratory Syncytial Virus (RSV) for adults aged 60 and up, made by GSK. The…